Page last updated: 2024-11-02

pd 98059 and Venous Insufficiency

pd 98059 has been researched along with Venous Insufficiency in 1 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Venous Insufficiency: Impaired venous blood flow or venous return (venous stasis), usually caused by inadequate venous valves. Venous insufficiency often occurs in the legs, and is associated with EDEMA and sometimes with VENOUS STASIS ULCERS at the ankle.

Research Excerpts

ExcerptRelevanceReference
" All experimental conditions were determined by dose-response and time-course experiments."1.35Regulation of matrix contraction in chronic venous disease. ( Durán, WN; Lal, BK; Ohara, N; Pappas, PJ; Saito, S; Zapiach, L, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pappas, PJ1
Lal, BK1
Ohara, N1
Saito, S1
Zapiach, L1
Durán, WN1

Other Studies

1 other study available for pd 98059 and Venous Insufficiency

ArticleYear
Regulation of matrix contraction in chronic venous disease.
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2009, Volume: 38, Issue:4

    Topics: Actins; Case-Control Studies; Cells, Cultured; Chronic Disease; Collagen; Dose-Response Relationship

2009